Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
Condition(s):ChoroideremiaLast Updated:December 7, 2020Recruiting
Include Studies Not Open or Pending
Condition(s):ChoroideremiaLast Updated:December 7, 2020Recruiting
Condition(s):ChoroideremiaLast Updated:April 2, 2021Recruiting
Condition(s):ChoroideremiaLast Updated:March 23, 2021Recruiting
Condition(s):Stargardts; Retinitis Pigmentosa; Age-related Macular Degeneration; Choroideremia; Geographic AtrophyLast Updated:December 17, 2020Recruiting
Condition(s):Eye Diseases Hereditary; Retinal Disease; Achromatopsia; Bardet-Biedl Syndrome; Bassen-Kornzweig Syndrome; Batten Disease; Best Disease; Choroidal Dystrophy; Choroideremia; Cone Dystrophy; Cone-Rod Dystrophy; Congenital Stationary Night Blindness; Enhanced S-Cone Syndrome; Fundus Albipunctatus; Goldmann-Favre Syndrome; Gyrate Atrophy; Juvenile Macular Degeneration; Kearns-Sayre Syndrome; Leber Congenital Amaurosis; Refsum Syndrome; Retinitis Pigmentosa; Retinitis Punctata Albescens; Retinoschisis; Rod-Cone Dystrophy; Rod Dystrophy; Rod Monochromacy; Stargardt Disease; Usher SyndromeLast Updated:December 13, 2018Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.